Walleye Capital
OPRX icon

Walleye Capital’s OptimizeRx OPRX Stock Holding History

Walleye Capital’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25,108
Closed -$339K – 4951
2025
Q2 		$339K Buy
25,108
+14,677
+141% +$161K ﹤0.01% 2959
2025
Q1 		$90.3K Sell
10,431
-128,144
-92% -$783K ﹤0.01% 3661
2024
Q4 		$673K Buy
+138,575
New +$774K ﹤0.01% 2737
2023
Q4 		– Sell
-23,471
Closed -$183K – 5360
2023
Q3 		$183K Buy
+23,471
New +$255K ﹤0.01% 3611
2023
Q2 		– Sell
-15,857
Closed -$232K – 4738
2023
Q1 		$232K Buy
15,857
+5,357
+51% +$89.6K ﹤0.01% 2342
2022
Q4 		$176K Sell
10,500
-80,614
-88% -$1.39M ﹤0.01% 2118
2022
Q3 		$1.35M Buy
+91,114
New +$1.8M 0.03% 770
2022
Q1 		– Sell
-8,338
Closed -$518K – 2508
2021
Q4 		$518K Buy
8,338
+5,749
+222% +$436K 0.02% 966
2021
Q3 		$221 Buy
+2,589
New +$162K 0.01% 1161

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Walleye Capital's OPRX Position: Q3 2025 in Review

Walleye Capital sold out of OptimizeRx (OPRX) in Q3 2025, closing a stake of 25,108 shares — an estimated $339K sold.

Walleye Capital first reported a position in OPRX in Q3 2021 and held it in 9 quarters. The position peaked at $1.35M in Q3 2022. 125 funds tracked by Wall St. Rank hold OPRX as of Q3 2025.

  • Walleye Capital reported no remaining OptimizeRx position as of Q3 2025 after selling out during the quarter.
  • Walleye Capital sold 25,108 OptimizeRx shares in Q3 2025, an estimated $339K.
  • Walleye Capital first reported a position in OptimizeRx in Q3 2021 and held it in 9 quarters.
  • Walleye Capital's OptimizeRx position peaked at $1.35M in Q3 2022.
  • 125 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2025.

Based on Walleye Capital's 13F filing for Q3 2025, filed 14 Nov 2025.